Cancer Outcomes Following Coronary Revascularization: Should We Be Looking Beyond Bleeding?
作者信息
Stein-Merlob Ashley F, Yang Eric H
机构信息
UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine University of California at Los Angeles Los Angeles CA USA.
出版信息
J Am Heart Assoc. 2025 May 6;14(9):e040356. doi: 10.1161/JAHA.125.040356. Epub 2025 Apr 16.
Abstract
摘要
相似文献
1
Cancer Outcomes Following Coronary Revascularization: Should We Be Looking Beyond Bleeding?冠状动脉血运重建后的癌症预后：我们是否应该超越出血问题去关注？
J Am Heart Assoc. 2025 May 6;14(9):e040356. doi: 10.1161/JAHA.125.040356. Epub 2025 Apr 16.
2
Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI.急性ST段抬高型心肌梗死支架植入术后靶血管血运重建的预测因素及影响：来自HORIZONS-AMI研究的经验教训
Am Heart J. 2015 Feb;169(2):242-8. doi: 10.1016/j.ahj.2014.11.005. Epub 2014 Nov 12.
3
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.冠状动脉旁路移植术后与经皮冠状动脉介入治疗术后外科手术的发生率及转归：来自京都PCI/CABG注册队列2的冠状动脉血运重建疗效研究报告
Circ Cardiovasc Interv. 2014 Aug;7(4):482-91. doi: 10.1161/CIRCINTERVENTIONS.113.001056. Epub 2014 Jul 29.
4
Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease.左主干病变经皮冠状动脉介入治疗后靶病变血运重建对长期死亡率的影响。
JACC Cardiovasc Interv. 2024 Jan 8;17(1):32-42. doi: 10.1016/j.jcin.2023.10.068.
5
Functional coronary angiography to indicate and guide revascularization in STEMI patients with multivessel disease: Rationale and design of the AIR-STEMI trial.功能性冠状动脉造影用于指导多支血管病变的ST段抬高型心肌梗死患者的血运重建：AIR-STEMI试验的原理与设计
Am Heart J. 2025 Jun;284:71-80. doi: 10.1016/j.ahj.2025.02.012. Epub 2025 Feb 19.
6
Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes.经桡动脉与经股动脉途径行冠状动脉旁路移植术治疗无保护左主干病变的比较：手术操作及长期预后比较。
JACC Cardiovasc Interv. 2010 Oct;3(10):1035-42. doi: 10.1016/j.jcin.2010.09.003.
7
Impact of impaired renal function on outcomes of chronic total occlusion undergoing revascularization: a systemic review and meta-analysis.肾功能受损对接受血运重建的慢性完全闭塞病变患者结局的影响：系统评价和荟萃分析。
Int Urol Nephrol. 2022 Dec;54(12):3179-3191. doi: 10.1007/s11255-022-03192-7. Epub 2022 Jun 11.
8
10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.左主干冠状动脉疾病中支架与冠状动脉旁路移植术的 10 年结果比较。
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2813-2822. doi: 10.1016/j.jacc.2018.09.012. Epub 2018 Sep 24.
9
Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-Analysis.经导管主动脉瓣植入术联合或不联合经皮冠状动脉血运重建策略：一项系统评价与荟萃分析
J Am Heart Assoc. 2017 Jun 27;6(6):e005960. doi: 10.1161/JAHA.117.005960.
10
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial.外周动脉疾病中的操作出血影响：EUCLID 试验分析。
Circ Cardiovasc Interv. 2019 Oct;12(10):e008069. doi: 10.1161/CIRCINTERVENTIONS.119.008069. Epub 2019 Oct 4.
本文引用的文献
1
Association Between Time From Percutaneous Coronary Intervention to Cancer Surgery and Cardiovascular and Oncological Outcomes.经皮冠状动脉介入治疗至癌症手术的时间与心血管及肿瘤学结局之间的关联。
J Am Heart Assoc. 2025 May 6;14(9):e038569. doi: 10.1161/JAHA.124.038569. Epub 2025 Apr 16.
2
Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment.癌症人群中的缺血性心脏病：趋势、结局、流行病学，以及诊断和治疗中的挑战。
Cardiol Clin. 2025 Feb;43(1):57-67. doi: 10.1016/j.ccl.2024.08.001. Epub 2024 Sep 27.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据：全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Cancer and the risk of perioperative arterial ischaemic events.癌症与围手术期动脉缺血事件的风险。
Eur Heart J Qual Care Clin Outcomes. 2024 Jun 20;10(4):345-356. doi: 10.1093/ehjqcco/qcad057.
5
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study.癌症患者 ST 段抬高型心肌梗死的转归：一项全国性研究。
Eur Heart J Qual Care Clin Outcomes. 2023 Dec 22;9(8):806-817. doi: 10.1093/ehjqcco/qcad012.
6
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019.1999 年至 2019 年期间美国癌症患者心血管疾病特定病因的死亡时间趋势。
Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):54-63. doi: 10.1093/ehjqcco/qcac016.
7
Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis.逆转肿瘤心脏病学：探究心血管疾病对癌症发病机制的影响。
J Mol Cell Cardiol. 2022 Feb;163:1-8. doi: 10.1016/j.yjmcc.2021.09.008. Epub 2021 Sep 25.
8
Myocardial infarction accelerates breast cancer via innate immune reprogramming.心肌梗死通过固有免疫重编程加速乳腺癌进展。
Nat Med. 2020 Sep;26(9):1452-1458. doi: 10.1038/s41591-020-0964-7. Epub 2020 Jul 13.
9
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease.逆向心血管肿瘤学：心血管疾病患者的癌症发展
J Am Heart Assoc. 2020 Jan 21;9(2):e013754. doi: 10.1161/JAHA.119.013754.
10
Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.经皮冠状动脉介入治疗在癌症患者中的应用：美国的流行率和结局报告。
Eur Heart J. 2019 Jun 7;40(22):1790-1800. doi: 10.1093/eurheartj/ehy769.
Zotero 插件